Delfi Diagnostics

Foresight Diagnostics

This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.

Mercy BioAnalytics

This company develops blood-based liquid biopsy tests for early cancer detection, serving healthcare providers, pharmaceutical companies and clinical trial organisers.

AnchorDx

This company develops non-invasive liquid biopsy tests and diagnostic tools for early cancer screening, diagnosis and recurrence monitoring for healthcare providers and patients.

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.

Epiliquid

This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.

Adela

The company develops blood-based genomic tests for early cancer detection and minimal residual disease monitoring for healthcare providers and biopharmaceutical partners.

Thrive Earlier Detection

This digital health company develops a multi-cancer liquid biopsy test to help healthcare providers detect various cancers through early-stage blood screening.

Naveris

This molecular diagnostics company develops and commercialises liquid biopsy tests for the early detection and clinical management of viral-associated cancers for healthcare providers.